Venus Concept

Venus Concept Current Liabilities

Delisted

The Current Liabilities of Venus Concept (VERO) as of Oct 23, 2026 is 47.92 M USD. In the previous year, Current Liabilities was 47.46 M USD — a change of 0.97% (higher).

Current Liabilities

47.92 MUSD

YoY

0.97%

Last updated:

Current Liabilities of Venus Concept is 2024 47.92 M USD. Current Liabilities of Venus Concept was 2023 47.46 M USD. It decreases by 0.97% higher compared to the previous year.

The Venus Concept Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2017
21.83 M USD
Jan 1, 2018
11.67 M USD
Jan 1, 2019
61.96 M USD
Jan 1, 2020
49.08 M USD
Jan 1, 2021
51.02 M USD
Jan 1, 2022
62.52 M USD
Jan 1, 2023
47.46 M USD
Jan 1, 2024
47.92 M USD
The Venus Concept Current Liabilities history
YEARCurrent LiabilitiesYoY
47.92 MUSD+0.97%
47.46 MUSD-24.08%
62.52 MUSD+22.54%
51.02 MUSD+3.95%
49.08 MUSD-20.79%
61.96 MUSD+431.20%
11.67 MUSD-46.56%
21.83 MUSD+4.96%
20.80 MUSD+192.97%
7.10 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Venus Concept Stock analysis

What does Venus Concept do? Venus Concept, Inc. generates revenue through its portfolio of medical aesthetic and hair restoration technologies, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin, and Venus Bliss. The company sells these products to clinics and medical practices globally, operating in over 60 countries and 29 direct markets. Its hair restoration division features NeoGraft, an automated system for follicular unit extraction (FUE) procedures. Venus Viva combines NanoFractional Radio Frequency (RF) and SmartScan technology for facial, neck, and body treatments, while Venus Fiore targets vaginal health restoration with three specialized applicators. The company’s revenue streams include direct sales of devices and related practice enhancement services. Products like Venus Legacy and Venus Freeze Plus are marketed for non-invasive aesthetic procedures, while NeoGraft serves the hair restoration segment. Venus Fiore focuses on internal vaginal health, labia tightening, and mons pubis reduction, addressing niche medical needs. All offerings are distributed through the company’s global network, leveraging its presence in 29 direct markets. Venus Concept’s business model centers on selling minimally invasive and non-invasive medical aesthetic technologies to healthcare providers. The company’s product range spans multiple applications, from facial rejuvenation to hair restoration and intimate health. By maintaining a diverse portfolio under its branded products, Venus Concept ensures steady demand across various medical specialties and geographic regions. Venus Concept is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Venus Concept stock

Current Liabilities of Venus Concept is 47.92 M USD in 2024.

Current Liabilities of Venus Concept changed from 47.46 M USD to 47.92 M USD, representing a 0.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Venus Concept since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Venus Concept historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Venus Concept

All Key Metrics — Venus Concept